APA (7th ed.) Citation

EM, S., SJ, G., D, C., CS, H., H, D., S, H., . . . C, L. (2024). Lower uromodulin serum levels are associated with poorer prognosis in patients with cirrhosis and hepatorenal syndrome type 2. American journal of physiology. Gastrointestinal and liver physiology, 326(5), G583. https://doi.org/10.1152/ajpgi.00304.2023

Chicago Style (17th ed.) Citation

EM, Schleicher, et al. "Lower Uromodulin Serum Levels Are Associated with Poorer Prognosis in Patients with Cirrhosis and Hepatorenal Syndrome Type 2." American Journal of Physiology. Gastrointestinal and Liver Physiology 326, no. 5 (2024): G583. https://doi.org/10.1152/ajpgi.00304.2023.

MLA (9th ed.) Citation

EM, Schleicher, et al. "Lower Uromodulin Serum Levels Are Associated with Poorer Prognosis in Patients with Cirrhosis and Hepatorenal Syndrome Type 2." American Journal of Physiology. Gastrointestinal and Liver Physiology, vol. 326, no. 5, 2024, p. G583, https://doi.org/10.1152/ajpgi.00304.2023.